Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid
Authors Nanda SS, An SSA, Yi DK
Received 14 October 2014
Accepted for publication 26 November 2014
Published 12 January 2015 Volume 2015:10(1) Pages 549—556
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Prof. Dr. Thomas J. Webster
Sitansu Sekhar Nanda,1 Seong Soo A An,1 Dong Kee Yi2,3
1Department of Bionanotechnology, Gachon University, Seongnam, South Korea; 2Department of Chemistry, 3Department of Environmental Engineering, Myongji University, Yongin, South Korea
Abstract: Oxidative stress can damage proteins, DNA, and lipids, and is involved in the progression of many diseases. Damage to infected cells caused by oxidative stress is related to increased levels of reactive oxygen species, including hydrogen peroxide. During oxidative stress, hydrogen peroxide levels are often increased and catalase level decreased inside cells. This can lead to the death of skin and other cells. Hydrophobic low molecular weight compounds are useful in treating hemorrhagic conditions of the skin. To this end, cystamine has been successfully conjugated with graphene oxide (GO) as a drug carrier. The current study used the microdilution method to determine the minimum inhibitory concentrations of cystamine-conjugated GO against four types of pathogenic bacteria. Minimum inhibitory concentrations values were 1 µg/mL against Escherichia coli and Salmonella typhimurium, 6 µg/mL against Enterococcus faecalis, and 4 µg/mL against Bacillus subtilis. Toxicity of the conjugate against squamous cell carcinoma 7 cells was minimal at low concentrations, but increased in a dose-dependent manner. These results demonstrated that our protocol produced a cystamine-conjugated GO with low cytotoxicity, but strong reactive oxygen species effects and high antibacterial activity. This nanohybrid may be useful in the treatment of dermatological disorders. Moreover, this class of nanohybrid may have other biomedical applications due to their low cytotoxicity and high antibacterial activity.
Keywords: graphene, oxide, cystamine conjugate, reactive oxygen species, antibacterial, oxidative stress
The cellular generation of reactive oxygen species (ROS) exposes aerobic living organisms to what is referred to as the “oxygen paradox”; a situation where oxygen is necessary for life but potentially hazardous because the ROS produced may cause cell and tissue injury. These effects of oxygen on living organisms are recognized by extensive free radical research.1–9
Graphene oxide (GO) has a large surface area that can be used for the immobilization of various biomolecules. GO has been proposed as a candidate for drug delivery.10,11 Although the biological applications of GO have not been well-studied, its biocompatibility was studied successfully in fibroblast cells (L-929)12 and it has been employed as a carrier for controlled drug delivery and the release of anticancer drugs.13,14 Previous studies also reported that graphene induced oxidative stress on neural pheochromocytoma-derived PC12 cells,15 and Liu et al reported PEGylated nano-GO could be used to deliver water insoluble anticancer drugs without any toxicity.10,11
After oxidation, hydroxyl and carboxyl groups are formed in GO and, when conjugated, such particles can be effectively dispersed in aqueous solutions.16 By conjugating GO with cystamine, we designed a material expected to induce cell death by generating ROS. Cystamine contains disulfide bonds (S-S) that are a primary structural component of some proteins.17 For example, disulfide bonds are found in cell-surface proteins.17 ERO1 is classified as a sulfhydryl oxidase. Experiments have shown that the ERO1 protein contains ERO1α and ERO1β that convert oxygen to hydrogen peroxide (H2O2).18,19 In order to increase the production of ROS, we conjugated cystamine with GO, which can easily interact with sulfhydryl oxidases.19
Various studies have shown the antibacterial activity of graphene-based materials. Hu et al examined the activity of graphene-based antibacterial activity toward Escherichia coli DH5α.20 Similarly, Akhavan and Ghaderi demonstrated the toxicity of graphene and GO nanowalls toward E. coli and Staphylococcus aureus.21 Lim et al studied the fabrication of graphene-chitosan composite films and investigated their antibacterial properties.22 Krishnamoorthy et al reported the antibacterial activity of GO-decorated textile fabrics against E. coli and S. aureus.23 Recently, graphene functionalized antimicrobial peptides have been used for the bioselective detection of bacteria at cellular levels.24 These studies motivated us to investigate the antibacterial activity of cystamine-conjugated GO.
The present research emphasized a new family of cystamine-conjugated and GO-mediated drug delivery systems. Here, we described the chemical synthesis of this nanocarrier. Fourier transform infrared spectroscopy was used to elucidate the interaction between constituents and to characterize the product of the chemical synthesis. All toxicity experiments were performed using murine squamous cell carcinoma (SCC7) cells.
Materials and methods
Synthesis of GO
The synthesis of GO was carried out through a modification of Hummer’s method.28 Briefly, a mixture of graphite flakes (2 g) and sodium nitrate (1 g) was cooled to 0°C in an ice bath. Concentrated sulfuric acid (60 mL) was added to the mixture and then potassium permanganate (9 g) was added slowly to keep the reaction temperature below 5°C. When the addition of potassium permanganate was complete, the reaction mixture was warmed to 35°C and stirred for 7 hours. The reaction mixture was then cooled to room temperature and poured into ice water (55 mL). Then, 7 mL of hydrogen peroxide was added, followed by the addition of 90 mL of ice water after separation. The reaction was subsequently stirred for 7 hours and then subjected to filtration. After filtration, the product was washed three times with hydrochloric acid and then with deionized water for 120 hours. All chemicals were purchased from Sigma-Aldrich Co. (St Louis, MO, USA) except hydrogen peroxide which was purchased from Daejon Chemicals.
Synthesis of cystamine-conjugated GO
Aqueous suspensions of GO (1 mg/mL in 10 mL) were prepared by sonicating GO for 1 hour. Cystamine conjugation was performed by adding GO suspensions (50 μg/mL) to a buffered solution of cystamine (2 mg of cystamine in 10 mM Tris buffer, pH 8.5). After shaking for 2 hours, conjugated GO was collected on a cellulose membrane filter, washed three times with deionized water, and dried under vacuum.
Viability of SCC7 cells treated with cystamine-conjugated GO
Murine SCC7 cells were cultured with cystamine-conjugated GO for 24 hours at concentrations from 5–300 μg/mL. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to measure cell survival as a percentage of viable cells in comparison to untreated controls. After treatment with cystamine-conjugated GO, 200 μL of a 0.5 g/L MTT solution in Roswell Park Memorial Institute medium-1640 (1:10) was added to each well. Cells were incubated at 37°C for 2 hours to allow color to develop, and 200 μL of 20% dimethyl sulfoxide was added. Absorbance was measured at 570 nm.
Production of ROS by cystamine-conjugated GO
The oxidant-sensitive dye 2′,7′-dichlorofluorescein diacetate (DCFH-DA) was used to assess the production of ROS. SCC7 cells were plated in 96-well plates (5×103 cells per well) and incubated for 24 hours. Cells were then treated with 5–200 μg/mL GO or cystamine-conjugated GO and incubated for an additional 24 hours. Positive controls involved culturing cells in the presence of 200 mM H2O2 prepared 1 hour before adding to cells loaded with the DCFH-DA probe. The probe was loaded into cells by replacing the culture medium with 100 μL of fresh medium containing 20 μM DCFH-DA. Cells were washed with D-Hank’s buffer solution after 1 hour. Then, 100 μL of D-Hank’s buffer solution was added to each well and fluorescence intensity measured using a microplate reader at 485 nm.
Relative amounts of ROS were calculated as (Ftest-Fblank)/(Fcontrol-Fblank), where Ftest is the fluorescence intensity of the SCC7 cells treated with GO or cystamine-conjugated GO, or the positive control, Fcontrol is the fluorescence intensity of the control SCC7 cells, and Fblank is the fluorescence intensity of the wells without SCC7 cells.
Antibacterial activity of cystamine-conjugated GO
The microdilution method was used with two Gram-negative bacterial strains (E. coli [KACC 10005] and S. typhimurium [KCCM 40253]) and two Gram-positive bacterial strains (Bacillus subtilis [KACC 14394] and Enterococcus faecalis [KACC 13807]) to determine the antibacterial activity of cystamine-conjugated GO.25 LB was used as the diluent for both bacterial strains. Inoculates were prepared by suspending cells in sterile LB for 12 hours. Cystamine-conjugated GO and standards were placed in 96-well plates and 107 colony forming unit (CFU)/mL of cells were inoculated so that the final volume in each microwell was 0.2 mL. The plates were incubated at 35°C for 24 hours and absorbance read at 590 nm using a microplate reader. Minimum inhibitory concentrations (MIC) values were determined both before and after incubation.
A field emission scanning electron microscope (FE-SEM; JSM-7500F; JEOL, Tokyo, Japan), and an atomic force microscope (AFM; Nanoscope IIIa, Digital Instruments, Tonawanda, NY, USA) with a J scanner were used to assess the morphology of cystamine-conjugated GO and the cells. An Escalab MK II photoelectron spectrometer (VG Scientific Ltd., East Sussex, UK) was used for X-ray photoelectron spectroscopy (XPS) measurements. A Varian ultraviolet-visible spectrophotometer was used for measuring absorbance. A Varian 3100 Fourier transform infrared (FT-IR) (Excalibur series) spectrophotometer was used for FT-IR spectra measurements. A ZetaSizer (Nano-Z; Malvern Instruments, Malvern, UK) was used for zeta potential measurement.
Results and discussion
Under acidic conditions, FT-IR did not show any carbonyl peak at 1,680 cm−1, indicating that there was no cystamine conjugated with GO. We assumed, therefore, that cystamine was oxidized under the basic pH (8.5) conditions used in this study resulting in redox reactions and the conjugation of cystamine to GO.
AFM (Figure 1) and SEM (Figure 2) were used to characterize the surface morphology of cystamine-conjugated GO. These data clearly showed the formation of cystamine-conjugated GO via changes in the surface morphology. In Figure 1A, the vertical distance is about 0.8 nm, indicating the formation of single-layered GO. In Figure 1B, the vertical distance is about 1.2 nm, indicating the conjugation of cystamine with GO.29 SEM images of GO are shown in Figure 2A while cystamine-conjugated GO are clearly visible in Figure 2B.
Figure 1 Images of graphene oxide (GO) (A) and cystamine-conjugated GO (B) by atomic force microscope (AFM).
It is well known that unconjugated GO has bactericidal activity. In the current study, a strong biological effect against micro-organisms was always found with cystamine-conjugated GO (Figure 2B). Such nanoparticles interact with cells via disulfide bonds (S-S) and produce ROS. Therefore, we also performed a toxicity study with the SCC7 cell line. The results from the cytotoxicity tests indicated that cystamine-conjugated GO caused a dose-dependent decrease in cell viability (Figure 3A).
The stability of nanomaterials in a dispersed state is a major obstacle for their use in biomedicine.26 The zeta potential of cystamine-conjugated GO, and GO in an aqueous dispersion, were measured and found to be −19.2 and −49.4 mV, respectively. GO has a negative zeta potential due to the ionization of edge carboxylic groups. Our data are thus consistent with previous studies.30 The observed zeta potential of cystamine-conjugated GO was expected because colloidal stability within −25 to +25 mV is indicative of its stability when dispersed.27
The absorbance spectrum of cystamine-conjugated GO in suspension showed the same peak at 232 nm as unconjugated GO. An additional peak at 400 nm showed that cystamine-conjugated GO was present (Figure 4A). GO exhibits a π–π* transition band at 232 nm and a shoulder π–π* transition band at 400 nm. In contrast, the π–π* transition peak shifts to 400 nm for cystamine-conjugated GO, indicating that some groups on the GO surface are removed as the conjugated structure is created.29
Further characterization by FT-IR was performed to evaluate the conjugation of GO by cystamine. Briefly, the peaks at 3,350 and 3,180 cm−1 (amide [CO-NH] stretching) confirmed the presence of cystamine on GO (Figure 4B). The carbonyl peak at 1,680 cm−1 was a clear indication of cystamine conjugation with GO (Figure 4B).29
XPS measurements provided additional information about the nature of cystamine-conjugated GO. Both conjugated and unconjugated GO exhibited C=C (sp2), C-C (sp3), C=O (carbonyl), O-C=O (carboxyl), and C-O/C-O-C (hydroxyl and epoxy) groups (Figure 5).30 Figure 5A shows the C1S peaks of GO including C-O (hydroxyl and epoxy, 288.1 eV), C=O (carbonyl, 291.4 eV), C=C/C-C (284.7 eV), and O=C-O (carboxyl, 294.8 eV) species. The C=C/C-C peak was 45.36% of the total GO. C-O (hydroxyl and epoxy, 288.5 eV), C=O (carbonyl, 291.9 eV), and O=C-O (carboxyl, 294.5 eV) peaks are shown in Figure 5B and indicate cystamine conjugation with GO. The major species, C=C/C-C (284.7 eV), was reduced to 36.53% of the total. Moreover, we found 0.84% of sulfur and 1.07% of nitrogen in cystamine-conjugated GO (Figure S1). There was 38.72% oxygen present in GO and 43.21% present in cystamine-conjugated GO, confirming conjugation. At low concentrations, cystamine-conjugated GO produced more ROS as compared to GO, without any observed toxicity.31 There was, however, a decrease in SCC7 cell viability with cystamine-conjugated GO at high concentrations. The production of ROS by cystamine-conjugated GO was low when compared to carbon nanotubes and fullerene,32 indicating that external factors were responsible for ROS production. The oxidative stress induced by cystamine-conjugated GO, but not GO, increased at higher concentrations (Figure 3B). Thus, ROS were generated in a concentration-dependent manner when cells were exposed to cystamine-conjugated GO.
Figure 5 High resolution C1S XPS spectra of (A) GO and (B) cystamine-conjugated GO.
In this study, antibacterial activity was determined using the microdilution method.25 The MIC of cystamine-conjugated GO were 1 μg/mL against E. coli and S. typhimurium, 6 μg/mL against E. faecalis, and 4 μg/mL against B. subtilis. These data showed that cystamine-conjugated GO had significant antibacterial activity. A comparative analysis was performed with a standard drug aminoglycoside antibiotic, Kanamycin (Sigma-Adrich Co.). The MIC of Kanamycin were 64 μg/mL against E. coli and S. typhimurium, 128 μg/mL against E. faecalis and B. subtilis. Antimicrobial properties of carbon-based materials such as fullerenes, graphite oxide, carbon nanotubes, and nanocomposite forms were reported in previous studies.33–35 The general mechanism of antibacterial activity of carbon materials depends on the size, structure, and properties of the individual materials. In addition, nanoscale size distribution, high surface to volume ratio, and other physicochemical properties contribute to the antimicrobial effects.
The current results show that cystamine-conjugated GO is more toxic to Gram-negative bacteria than to Gram-positive bacteria. This result is consistent with the previous findings of Hu et al and Akhavan and Ghaderi.20,21 Hu et al in another study, demonstrated that graphene nanosheets disrupted the cell walls of E. coli, either through physical disruption or oxidative stress, resulting in the loss of cellular integrity.20 In our study, the differential toxicity of cystamine-conjugated GO toward Gram-negative bacteria compared to Gram-positive bacteria may be related to differences in the natures of their cell walls. A thin peptidoglycan layer (7-8 nm thickness) is present in Gram-negative bacteria whereas a thick peptidoglycan layer (20-80 nm thickness) is present in Gram-positive bacteria.21,36 The thicker peptidoglycan layer in Gram-positive bacteria may explain why these bacteria are more resistant to the antibacterial effects of cystamine-conjugated GO (Figure 6).
There is extensive ongoing research designed to expand our knowledge on the roles of oxidative stress and its mediators in human diseases such as atherosclerosis, cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders. In the current study, we found an increased production of ROS in the functionalization of cystamine-conjugated GO, and demonstrated that this material exhibits good antibacterial activity against two different Gram-positive, and two different Gram-negative bacteria. In order to elucidate the mechanism of ROS production, additional studies are needed. Nevertheless, these results suggest that cystamine-conjugated GO will have an important role in the field of biomedicine.
This work was supported by the GRRC program of Gyeonggi Province (GRRC Gachon 2013-B04, Development of Microfluidic Chip for Diagnosing Diseases).
The authors have no conflicts of interest to disclose.
Commoner B, Townsend J, Pake GE. Free radicals in biological materials. Nature. 1954;174(4432):689–691.
Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11(3):298–300.
Slater TF. Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature. 1966;209(5018): 36–40.
McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22): 6049–6055.
Slater TF. Free Radical Mechanisms in Tissue Injury. London, UK: Pion Ltd; 1972.
Harman D. The aging process. Proc Natl Acad Sci U S A. 1981;78(11): 7124–7128.
Cadenas E. Biochemistry of oxygen toxicity. Ann Rev Biochem. 1989; 58:79–110.
8.Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 2000;29(3–4):222–230.
West JD, Marnett LJ. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol. 2006;19(2): 173–194.
Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130(33): 10876–10877.
Sun X, Liu Z, Welsher K, et al. Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res. 2008;1(3):203–212.
Schipper ML, Ratchford NN, Davis CR, et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol. 2008;3(4):216–221.
Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2009;6(4):537–544.
Yang X, Zhang X, Liu Z, Ma Y, Huang Y, Chen, Y. High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide. J Phys Chem C. 2008;112:17554–17558.
Zhang YB, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010;4(6):3181–3186.
Becerril HA, Mao J, Liu Z, Stoltenberg RM, Bao Z, Chen Y. Evaluation of solution-processed reduced graphene oxide films as transparent conductors. ACS Nano. 2008;2(3):463–470.
Gross E, Sevier CS, Heldman N, et al. Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc Natl Acad Sci U S A. 2006;103(2): 299–304.
Baker KM, Chakravarthi S, Langton KP, Sheppard AM, Lu H, Bulleid NJ. Low reduction potential of Ero1alpha regulatory disulphides ensures tight control of substrate oxidation. EMBO J. 2008;27(22): 2988–2997.
Wang L, Zhu L, Wang CC. The endoplasmic reticulum sulfhydryl oxidase Ero1beta drives efficient oxidative protein folding with loose regulation. Biochem J. 2011;434(1):113–121.
Hu W, Peng C, Luo W, et al. Graphene-based antibacterial paper. ACS Nano. 2010;4(7):4317-4323.
Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4(10):5731-5736.
Lim HN, Huang NM, Loo CH. Facile preparation of graphene-based chitosan films: Enhanced thermal, mechanical and antibacterial properties. J Non-Cryst Solids. 2012;358:525-530.
Krishnamoorthy K, Navaneethaiyer U, Mohan R, Lee J, Kim S. Antibacterial Efficiency of Graphene Nanosheets against Pathogenic Bacteria via Lipid Peroxidation. J Appl Nanosci. 2012;2:119-126.
Mannoor MS, Tao H, Clayton JD, et al. Graphene-based wireless bacteria detection on tooth enamel. Nat Commun. 2012;3:763.
Amsterdam D. In: Lorian V, editor. Susceptibility Testing of Antimicrobials in Liquid Media. Baltimore, MD: Lippincott Williams & Wilkins; 1996;52:111.
Fang C, Bhattarai N, Sun C, Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small. 2009;5(14): 1637-1641.
Lotya M, Hernandez Y, King PJ, et al. Liquid phase production of graphene by exfoliation of graphite in surfactant/water solutions. J Am Chem Soc. 2009;131(10):3611-3620.
Hummers WS, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80:1339–1339.
Yang S, Xiaosheng T, Erwin P, Junmin X. Graphene oxide based fluorescent nanocomposites for cellular imaging. Journal of material chemistry B. 2013;1:512.
Shin HJ, Kim KK, Benayad A, et al. Efficient Reduction of Graphite Oxide by Sodium Borohydride and Its Effect on Electrical Conductance. Adv Funct Mater. 2009;19:1987–1992.
Yanli C, Sheng YT, Hui LJ, et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett. 2011;200(3):201–210.
Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4(1):26–49.
Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010;4(6):3181-3186.
Garza KM, Soto KF, Murr LE. Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulate materials. Int J Nanomed. 2008;3(1):83-94.
Niu A, Han Y, Wu J, Yu N, Xu Q. Synthesis of One-Dimensional Carbon Nanomaterials Wrapped by Silver Nanoparticles and Their Antibacterial Behavior. J Phys Chem C. 2010;114:12728-12735.
Eaton P, Fernandes JC, Pereira E, Pintado ME, Malcata FX. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. Ultramicroscopy. 2008; 108(10):1128-1134.
Figure S1 High resolution (A) N1S XPS spectra (B) S1S XPS spectra.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]